, Volume 9, Issue 1, pp 39–43 | Cite as

Evaluation of RU58841 as an anti-androgen in prostate PC3 cells and a topical anti-alopecia agent in the bald scalp of stumptailed macaques

  • Huei-Ju Pan
  • George Wilding
  • Hideo Uno
  • Shigeki Inui
  • Lowell Goldsmith
  • Edward Messing
  • Chawnshang ChangEmail author


The effect of androgen receptor transcriptional activation by RU58841, a nonsteroidal anti-androgen, was studied in the human prostate cancer PC3 cell line by cotransfection with wild-type androgen receptor (wt AR) and an androgen-responsive reporter (MMTV-ARE-CAT) construct. Anti-androgens, hydroxyflutamide, and Casodex, and the antiestrogen, genistein, were studied in parallel for comparison with RU58841. The wt AR was activated only by the androgen dihydrotestosterone (DHT). Neither the anti-androgens nor antiestrogen can enhance AR transcriptional activity at 10−11-10−7 M in PC3 cells. Hydroxyflutamide, RU58841, and Casodex, but not genistein, displayed competitively suppressive effects on DHT activation of wt AR. The potency of RU58841 was comparable to that of hydroxyflutamide. From this result, topical application of RU58841, which is considered to be a potential therapy for skin diseases, may induce systemic side effects. However, RU58841, on topical application, revealed a potent increase in density, thickening, and length of hair in the macaque model of androgenetic alopecia, whereas no systemic effects were detected. Together our results suggest that RU58841 may have potent antagonism to the wt AR and could be considered as a topically applied active anti-androgen for the treatment of androgen-dependent skin disorders, such as acne, androgenetic alopecia, and hirsutism.

Key Words

Hydroxyflutamide Casodex alopecia prostate 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Neumann, F. and Topert, M. (1986). J. Steroid Biochem. 25, 885–895.CrossRefPubMedGoogle Scholar
  2. 2.
    Raynaud, J.-P. and Ojasoo, T. (1986). J. Steroid Biochem. 25, 811–833.CrossRefPubMedGoogle Scholar
  3. 3.
    Walkeling, A. E. (1992). Cancer Surveys 14, 71–85.Google Scholar
  4. 4.
    Beato, M. (1989). Cell 56, 335–344.CrossRefPubMedGoogle Scholar
  5. 5.
    Carson-Jurica, M. A., Schrader, W. T., and O’Malley, B. W. (1990). Endocr. Rev. 11, 201–220.PubMedGoogle Scholar
  6. 6.
    Moguilewsky, M. and Bouton, M. M. (1988). J. Steroid Biochem. 31, 699–710.CrossRefPubMedGoogle Scholar
  7. 7.
    Neri, R. and Kassem, N. (1987). In: Pharmacology and Clinical Uses of Inhibitors of Hormone Secretion and Action. Furr, B. J. A. and Wakeling, A. E. (eds.). Bailliere Tindall, London, pp. 160–169.Google Scholar
  8. 8.
    Moguilewsky, M., Bertagna, C., and Hucher, M. (1987). J. Steroid Biochem. 27, 871–875.CrossRefPubMedGoogle Scholar
  9. 9.
    Moguilewsky, M., Cotard, M., Proulx, L., Tournemine, C., and Raynaud, J. P. (1987). In: Prostate Cancer, Part A: Research, Endocrine Treatment, and Histopathology Progress in Clinical and Biological Research, vol. 243A. Murphy, G., Khoury, S., Kuss, R., Chatelain, C., and Denis, L. (eds.). Alan Liss, New York, 243A, pp. 315–340.Google Scholar
  10. 10.
    Harris, M. G., Coleman, S. G., Faulds, D., and Chrisp, P. (1993). Drugs Aging 3, 9–25.PubMedGoogle Scholar
  11. 11.
    Furr, B. J. A., Curry, V. B., Woodburn, J. R., Chesterson, R., and Tucker, H. (1987). J. Endocr. 113(3), R7-R9.PubMedGoogle Scholar
  12. 12.
    Teutsch, G., Goubet, F., Battmann, T., Bonfils, A., Bouchoux, F., Cerede, E., et al. (1994). J. Steroid Biochem. Mol. Biol. 48, 111–119.CrossRefPubMedGoogle Scholar
  13. 13.
    Battmann, T., Bonfils, C., Branche, C., Humbert, J., Goubet, F., Teutsch, G., et al. (1994). J. Steroid Biochem. Mol. Biol. 48, 55–60.CrossRefPubMedGoogle Scholar
  14. 14.
    Martin, P. M., Horwitz, K. B., Ryan, D. S., and McGuire, W. L. (1978). Endocrinology 103, 1860–1867.PubMedCrossRefGoogle Scholar
  15. 15.
    Makela, S., Davis, V., Tally, W. C., Korkman, J., Salo, L., Vihko, R., et al. (1994). Environ. Health Perspect. 102, 572–578.PubMedGoogle Scholar
  16. 16.
    Messina, M. J., Persky, V., Setchell, K. D. R., and Barnes, S. (1994). Nutr. Cancer 21, 113–131.PubMedCrossRefGoogle Scholar
  17. 17.
    Lutsky, B. N., Budak, M., Kozio, P., Monahan, M., and Neri, R. O. (1975). J. Invest. Dermatol. 64, 412–417.CrossRefPubMedGoogle Scholar
  18. 18.
    Uno, H. (1987). In: Models in Dermatology 3. Maibach, H. I., and Lowe, N. J. (eds.). S. Karger AG, Basel, pp. 159–169.Google Scholar
  19. 19.
    Uno, H. (1986). In: Seminars in Reproductive Endocrinology: Andrology in Woman, 4, Speroff, L. (ed.). Thieme-Stratton, New York, pp. 131–141.Google Scholar
  20. 20.
    Berrevoets, C. A., Veldscholte, J., and Mulder, E. (1993). J. Steroid Biochem. Mol. Biol. 46, 731–736.CrossRefPubMedGoogle Scholar
  21. 21.
    Yeh, S., Miyamoto, H., and Chang, C. (1997). Lancet 349, 852.CrossRefPubMedGoogle Scholar
  22. 22.
    Katzenellenbogen, J. A., O’Malley, B. W., and Katzenellenbogen, B. S. (1996). Mol. Endocrinolo. 10, 119–131.CrossRefGoogle Scholar
  23. 23.
    Ayub, M. and Levell, M. J. (1989). J. Steroid. Biochem. 33, 251–255.CrossRefPubMedGoogle Scholar
  24. 24.
    Furr, B. J. A. (1989). Horm. Res. 32, 69–76.PubMedCrossRefGoogle Scholar
  25. 25.
    Brouwer, B. D., Tetelin, C., Leroy, T., Bonfils, A., and Neste, D. V. (1997). Br. J. Dermatol. 137, 699–702.CrossRefPubMedGoogle Scholar
  26. 26.
    Gomez, E. C. and Frost, P. H. (1975). In: Animal Models in Dermatology—Relevance to Human Dermatopharmacology and Dermatotoxicology. Maibach, H. (ed.). Churchill Livingstone, Edinburgh, pp. 190–202.Google Scholar
  27. 27.
    Obana, N., Chang, C., and Uno, H. (1997). Endocrinology 138, 356–361.CrossRefPubMedGoogle Scholar
  28. 28.
    Chang, C., Kokontis, J., and Liao, S. (1988). Science 240, 324–326.CrossRefPubMedGoogle Scholar
  29. 29.
    Berns, E. M. J., De Boer, W., and Mulder, E. (1986). Prostate 9, 247–259.CrossRefPubMedGoogle Scholar
  30. 30.
    Nielsen, D. A., Chang, T.-C., and Shapiro, D. J. (1989). Anal. Biochem. 179(1), 19–23.CrossRefPubMedGoogle Scholar

Copyright information

© Humana Press Inc. 1998

Authors and Affiliations

  • Huei-Ju Pan
    • 1
    • 2
  • George Wilding
    • 2
  • Hideo Uno
    • 2
  • Shigeki Inui
    • 1
  • Lowell Goldsmith
    • 1
  • Edward Messing
    • 1
  • Chawnshang Chang
    • 1
    • 2
    Email author
  1. 1.George Whipple Laboratory for Cancer Research, Departments of Pathology, Urology, Dermatology and Radiation OncologyUniversity of Rochester Medical CenterRochester
  2. 2.University of Wisconsin Comprehensive Cancer Center and Regional Primate Research CenterMadison

Personalised recommendations